Back

Effects of PCSK9 inhibitor on adverse limb outcomes in patients with critical limb ischemia

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Peripheral Vascular and Cerebrovascular Disease ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Assistant Professor Yusuke Sato

University of Fukui, Fukui (Japan)

44 More presentations in this session

Presentation thumbnail
Atlas of the immune cell repertoire in human atherosclerotic plaques characterized by single cell RNA-sequencing and multi-color flow cytometry
Mr H. Horstmann (Freiburg, DE)
Abstract Slides
Presentation thumbnail
Peripheral artery disease impairs myocardial perfusion through increasing pulse wave reflection: The Northern Shanghai Study
Doctor S. Yu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Atrial fibrillation in a cohort of patients with peripheral arterial disease. A retrospective study of a healthcare database in UK.
Mr A. Vitalis (Colchester, GB)
Abstract Slides
Presentation thumbnail
Prevalence, specialized ambulatory care and guideline-recommended therapy of peripheral vascular diseases in Germany
Mrs O. Petrikhovich (Essen, DE)
Abstract Slides
Presentation thumbnail
Clinical impact of peripheral artery disease on acute coronary syndrome
Doctor F. Fonseca Goncalves (Vila Real, PT)
Abstract Slides

Access the full session

Session thumbnail
Peripheral Vascular and Cerebrovascular Disease ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
PCSK9 inhibitors and cardiovascular outcomes in AMI-BIRISK patients: a multicenter retrospective study
thumbnail
Congress Presentation
Early PCSK9 inhibitor subscription during episode of acute myocardial infarction (EPISODE-AMI) study
thumbnail
Congress Presentation
Effect of PCSK9 inhibitors on coronary plaque: a meta-analysis and trial sequential analysis

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources